New York State Common Retirement Fund Sells 254 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

New York State Common Retirement Fund reduced its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 1.5% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 16,647 shares of the company’s stock after selling 254 shares during the quarter. New York State Common Retirement Fund’s holdings in U.S. Physical Therapy were worth $1,551,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in USPH. Vanguard Group Inc. increased its position in U.S. Physical Therapy by 1.7% during the 3rd quarter. Vanguard Group Inc. now owns 1,036,203 shares of the company’s stock valued at $95,051,000 after purchasing an additional 17,156 shares during the period. Boston Trust Walden Corp increased its position in U.S. Physical Therapy by 0.7% during the 4th quarter. Boston Trust Walden Corp now owns 546,958 shares of the company’s stock valued at $50,944,000 after purchasing an additional 3,616 shares during the period. Schroder Investment Management Group increased its position in U.S. Physical Therapy by 12.1% during the 3rd quarter. Schroder Investment Management Group now owns 384,936 shares of the company’s stock valued at $35,310,000 after purchasing an additional 41,414 shares during the period. Northern Trust Corp increased its position in U.S. Physical Therapy by 9.5% during the 3rd quarter. Northern Trust Corp now owns 227,704 shares of the company’s stock valued at $20,887,000 after purchasing an additional 19,661 shares during the period. Finally, Envestnet Asset Management Inc. increased its position in U.S. Physical Therapy by 53.2% during the 3rd quarter. Envestnet Asset Management Inc. now owns 163,956 shares of the company’s stock valued at $15,040,000 after purchasing an additional 56,957 shares during the period.

U.S. Physical Therapy Stock Up 1.1 %

NYSE:USPH opened at $105.08 on Friday. The firm’s 50-day moving average price is $105.32 and its 200-day moving average price is $96.43. The company has a market capitalization of $1.58 billion, a PE ratio of 77.84, a P/E/G ratio of 4.99 and a beta of 1.39. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.28 and a quick ratio of 2.28. U.S. Physical Therapy, Inc. has a 1-year low of $78.08 and a 1-year high of $124.11.

U.S. Physical Therapy (NYSE:USPH) last released its earnings results on Tuesday, May 7th. The company reported $0.51 earnings per share for the quarter, missing analysts’ consensus estimates of $0.58 by ($0.07). The business had revenue of $155.70 million during the quarter, compared to analysts’ expectations of $153.30 million. U.S. Physical Therapy had a return on equity of 8.52% and a net margin of 4.67%. The firm’s quarterly revenue was up 4.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.59 earnings per share. On average, equities analysts predict that U.S. Physical Therapy, Inc. will post 2.77 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 14th. Shareholders of record on Thursday, May 23rd will be paid a dividend of $0.44 per share. The ex-dividend date of this dividend is Wednesday, May 22nd. This represents a $1.76 dividend on an annualized basis and a yield of 1.67%. U.S. Physical Therapy’s dividend payout ratio is currently 130.37%.

Insiders Place Their Bets

In other news, Director Edward L. Kuntz sold 2,500 shares of the stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $104.26, for a total transaction of $260,650.00. Following the sale, the director now owns 5,780 shares in the company, valued at $602,622.80. The transaction was disclosed in a filing with the SEC, which is available at this link. In other U.S. Physical Therapy news, insider Eric Joseph Williams sold 1,500 shares of the stock in a transaction on Monday, March 4th. The stock was sold at an average price of $104.96, for a total transaction of $157,440.00. Following the sale, the insider now directly owns 19,314 shares in the company, valued at approximately $2,027,197.44. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Edward L. Kuntz sold 2,500 shares of the stock in a transaction on Monday, March 4th. The shares were sold at an average price of $104.26, for a total value of $260,650.00. Following the sale, the director now owns 5,780 shares in the company, valued at $602,622.80. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 10,829 shares of company stock valued at $1,141,535. Insiders own 1.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. Barrington Research reissued an “outperform” rating and set a $122.00 price objective on shares of U.S. Physical Therapy in a research report on Thursday. JPMorgan Chase & Co. boosted their price objective on shares of U.S. Physical Therapy from $99.00 to $117.00 and gave the company an “overweight” rating in a research report on Wednesday, March 13th. Finally, StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Monday, March 18th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, U.S. Physical Therapy has an average rating of “Moderate Buy” and a consensus price target of $125.67.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.